The longer-acting agents (e.g. chlorpropamide, glyburide [glibenclamide], and sustained-release glipizide) are more likely to cause hypoglycemia than glipizide, glimepiride, and gliclazide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback